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ABSTRACT 
Purpose: To verify the effect of consumption of grape extract isolated or combined with α-tocopherol supplementation on atherosclerosis 
model with Apo E -/- mice. Methods: After six weeks of atherogenic diet, Apo E -/- mice were divided into the following groups: 
Control, Grape, Tocopherol and Grape plus Tocopherol. The treatment progressed for 11 weeks when animals were submitted to 
euthanasia. Results: All the treatments presented hypocholesterolemic effect with reduction of serum and liver cholesterol levels. This 
effect was parallel to an increase in the fecal excretion of cholesterol. There was also a higher fecal excretion of saturated fatty acids 
in groups receiving grape extract or α-tocopherol. All the groups treated presented a tendency to show higher levels of vitamin E. The 
fatty acid profile showed a tendency for monounsaturated fatty acid preservation after grape extract and α-tocopherol consumption. 
Morphological analysis revealed a lower degree of evolution of the atherosclerotic plaque of the animals that were fed α-tocopherol 
combined with grape extract, even when no difference was found in the size of the largest lesion. Conclusion: A synergistic effect 
between the polyphenols and α-tocopherol was observed, resulting in diminished evolution of atherosclerosis and a greater beneficial 
effect on atherosclerosis than the isolated consumption of antioxidants.
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RESUMO
Objetivo: Verificar o efeito do consumo de extrato de uva isolada ou combinada com a suplementação de α-tocoferol em modelo de 
aterosclerose, utilizando camundongos Apo E -/-. Métodos: Os camundongos Apo E -/- foram tratados com dieta aterogênica por seis 
semanas e foram divididos em quatro grupos: Controle, Uva, Tocoferol e Uva e Tocoferol. Após 11 semanas de tratamento os animais 
foram submetidos à eutanasia. Resultados: Todos os tratamentos apresentaram efeito hipocolesterolêmico, com redução de colesterol 
plasmático e hepático. Este efeito foi acompanhado de um aumento na excreção fecal de colesterol. Houve também uma maior excreção 
fecal de ácidos graxos saturados nos grupos que receberam extrato de uva ou de α-tocoferol. Todos os grupos apresentaram uma 
tendência a apresentar níveis mais elevados de vitamina E. O perfil de ácidos graxos mostrou uma tendência para a preservação de 
ácidos graxos monoinsaturados, após consumo de extrato de uva e α-tocoferol. A análise morfológica revelou um menor grau de 
evolução da placa aterosclerótica dos animais que foram alimentados com α-tocoferol combinado com extrato de uva, mesmo quando 
não houve diferença no tamanho da lesão. Conclusão: Foi observado um efeito sinergístico entre os polifenóis e α-tocoferol, resultando 
na redução na evolução da aterosclerose e um maior de efeito benéfico na aterosclerose do que o consumo isolado de antioxidantes sobre 
a aterosclerose do que o consumo isolado de antioxidantes.
Descritores: Colesterol LDL. Vitis. alfa-Tocoferol. Dieta Aterogênica. Camundongos.
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Introduction
The main causes of death in the western societies are 
cardiovascular diseases, whose major manifestations are: heart 
attacks, embolisms, and cerebral vascular accidents (CVA)1. 
Atherosclerosis is the main alteration involved in the process 
of cardiovascular diseases. It is characterized by the formation 
of atheroma plaques from the accumulation of lipids inside the 
macrophages, which is subsequently deposited in the vascular 
intima triggering an inflammatory response. This process seems to 
be directly linked with oxidative modification of the low-density 
lipoprotein-LDL (Low Density Lipoprotein) in the circulation2.
Therefore, oxidative modifications within the arterial wall 
may initiate and/or contribute to atherogenesis. The shift in the 
balance between oxidants and antioxidants in favor of the former 
would be one of the factors contributing to inflammatory responses 
and to a vicious cycle of lipid peroxidation within the lipoproteins 
and cellular recruitment for uptake of modified lipoproteins from 
circulation3. 
Many factors could contribute to compromise endogenous 
antioxidant defense system like high exposure to pathological agents 
of different origins or even a deficient diet4. In the context of the 
oxidative modification hypothesis, antioxidant protection of LDL in 
the extracellular space deserves focus, as oxidized LDL has many 
potential proatherogenic activities. Thus, the use of antioxidants 
through the diet could be a useful therapeutic measure applicable 
against LDL oxidative modification. 
Compounds able to prevent the consequences of radicals 
involved in lipid peroxidation through its inactivation could 
contribute to the maintenance of health or to reduce progression of 
atherosclerotic lesions. Red wine, white wine and grape juice all 
have high antioxidant potential to protect cellular structures against 
peroxidation reactions owing to their rich phenolic contents5. Grape 
juice is a rich source of antioxidant compounds as the flavonoids 
catechin, epicatechin, quercetin, and anthocyanins6. In vitro studies 
showed that grape juice has sufficient antioxidant activity to 
inhibit LDL oxidation7. At the same time high-dose α-tocopherol 
supplementation in humans decreases the susceptibility of LDL 
oxidation. Jialal et al.8 compared the effect of α-tocopherol in 
doses of 60, 200, 400, 800, and 1200 IU/d, and found that the 
minimum dose of α-tocopherol needed to significantly decrease the 
susceptibility of LDL to oxidation is 400 IU/d.
To better understand the action of dietary antioxidants on 
atherogenesis, this work was carried out to evaluate the influence 
of diet supplementation with grape juice extracted from Niagara 
grape (Vitis vinifera L.) and α-tocopherol on the development of 
atherosclerosis in Apo E-/- mice and the likely synergistic effect of 
the simultaneous use of antioxidants.
Methods 
Animals and diets
A total of 49 Apo E gene deficient 57BL/6 male and 
female mice of same age and similar weights were selected. The 
5-week old animals were fed atherogenic diet for six weeks. 
After this period, the animals were separated into 4 groups with 
different treatments. The experimental treatments consisted in: a) 
Control, fed atherogenic diet and water; b) Grape, fed atherogenic 
diet and Niagara grape extract; c) Tocopherol, fed atherogenic diet 
supplemented with 400mg of α-tocopherol acetate/Kg of diet and 
water; and d) Grape /Tocopherol, fed atherogenic diet supplemented 
with 400mg of α-tocopherol acetate /Kg of diet and Niagara grape 
extract diet. The diet, grape extract and water were given ad libitum 
and food intake was followed up weekly. The treatment lasted 11 
weeks when the animals were euthanized. 
The experimental diets were prepared according to 
A.O.A.C. protocol 19899. The aqueous grape extract was prepared 
using 1.5 kg of Niagara grape (Vitis vinifera L.) produced in 
northwestern São Paulo, Brazil, and purchased at a market in Viçosa-
MG, Brazil. The grapes were processed with seeds in a domestic 
blender with a total of 20 mL of distilled water and filtrated in a 
cotton cloth. The extract was stored at -25ºC, protected from light 
and oxygen. The dilution of the concentrated extract was made in 
the proportion 1:5 (extract/distilled water) for animal consumption. 
Experimental protocols used on this research were 
developed following Animal Experimentation Brazilian College 
rules and management recommendations.
Cholesterol and triacylglycerol dosage
Total cholesterol and triacylglycerol dosage in the 
serum, liver, and feces was performed by means of enzymatic kits 
(donated by KATAL and Bioclin Laboratories). Cholesterol and 
triacylglycerol were extracted from liver and feces according to 
Folch et al.10
Vitamin E dosage
Serum and liver vitamin E levels were analyzed by 
High-Performance Liquid Chromatography (HPLC), after vitamin 
extraction according to the method proposed by Ueda and Igarashi11. 
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The equipment consisted of a visible UV diode array detector 
(Shimadzu), Lichrospher column, RP-18 (4.0 x 250 mm, 5 µm). A 
mixture of acetonitrila, methanol and hexane was used as mobile 
phase in the ratio 3:95:2. Running flow was 1 mL/minute and 
running time was 10 minutes. The wavelength used in the detector 
corresponded to a maximum absorbance of α-tocopherol, 295 nm. 
The vitamin standard applied was α-tocopherol (Sigma-Aldrich®, 
EUA), dissolved in ethanol at 96%, resulting in a stock solution of 
100 µg/mL.
Soluble polyphenol dosage
Polyphenol determination was carried out in the grape 
extract, serum, liver and feces according to the method of Singleton 
and Rossi12, using gallic acid as standard.
Determination of the anthocyanins in the grape extract
Anthocyanin content was obtained based on the technique 
proposed by Lees and Francis13.
Malondialdehyde (MDA) dosage
Malondialdehyde (MDA) levels were determined in 
the liver according to the method developed by Gutteridge and 
Halliwell14. 
Lipid hydroperoxide dosage
Lipid peroxidation sub-products capable of oxidizing 
ferrous ions (Fe3+) into ferric (Fe2+) were determined in the serum 
and liver, according to the method proposed by Nourooz-Zadeh et 
al.15 
Fatty acid profile analysis
After lipid extraction from the liver and fecal tissues, 
saponification and esterification of the lipid extracts was carried out 
for gas chromatography (GC) analysis. The methodology applied for 
saponification and esterification of the lipid extract was proposed by 
Hartman and Lago16. For the chromatographic running, an aliquot 
of 1µL of the lipid extract solution was injected in hexane (50mg/
mL) in CG-17A Shimadzu/Class chromatograph, equipped with SP-
2560 (biscianopro2pil polysiloxane) used silica chromatographic 
column of 100m and 0.25mm diameter. The carrier gas (mobile 
phase) was nitrogen. Running started with the column temperature 
at 100ºC, increasing 10ºC/min until reaching 180ºC. After this 
period, the column temperature increased 1ºC/min until reaching 
240ºC, remaining at this temperature for 10 min. The injector and 
detector temperatures were 250ºC and 270ºC, respectively. Fatty 
acid identification considered the retention times of a standard fatty 
acid methyl ester (SupelcoTM 37 Component FAME Mix).
 
Morphological and morphometrical analyses
Morphological analysis of aorta artery was carried out 
according to classification proposed by Stary et al.17 The presence 
of specific histopathologic characteristics of six different degrees of 
atherosclerotic lesion was considered.
The morphometrical analysis was carried out using the 
area average of the three major lesions of each animal. The optical 
microscope Olympus Provis U-MCB, coupled to a Spot Insight 
Color digital camera and computer, was used to capture the images. 
The images were measured by means of the software Image-Pro 
Plus 4.5.
Ethics committee
This project was approved by the Ethics Committee of 
the Department of Veterinary Medicine of the Federal University 
of Viçosa, processed 13/2008, and the experiment was carried out 
according to the Ethical Principles in Animal Experimentation, 
adopted by the Brazilian College of Animal Experimentation 
(COBEA).
Statistical analysis
The ANOVA analysis of variance and Tukey test was 
used for comparison of symmetric data. The non-parametric test 
of Kruskal – Wallis complemented by the Dunn´s test of multiple 
comparisons was used for asymmetric data. For histological 
analysis, the statistical Qui-square test was applied. A significant 
level (p) below 5% was accepted, conferring the study a reliability 
of 95%. For data analysis, the software Sigma Stat 2.03 and the 
software EpiInfo 6 was used.
Results 
Animals and diets
The results did not show treatment influences on weighted 
gain, liver relative weight, and food consumption. The levels of 
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total polyphenols in the pure extract was 331.00 ± 51.00 mg/100g 
and anthocyanins 248.75 ± 132.45 mg/100g. Animals consumed 
an average of 9.7 mL daily, with a consumption of 32.11mg of 
polyphenols and 24.13 mg of anthocyanins. Alpha-tocopherol 
consumption was estimated to be ten times higher in those groups 
receiving this vitamin: 0.018, 0.175, 0.019 and 0.179 mg/week/
animal in the control, tocopherol, grape, and tocopherol plus grape, 
respectively.  
Cholesterol and triacylglycerol levels
The antioxidants supplementation was effective in 
influencing total serum cholesterol levels, specially the association 
of both antioxidants. Treated groups presented 15.71%, 35.8% 
and 43.5% smaller cholesterol levels in comparison with control 
group in animals given grape extract, α-tocopherol and both the 
antioxidants respectively. The smallest content of cholesterol in the 
liver was found in the group consuming grape extract in association 
with α-tocopherol, followed by animals fed only α-tocopherol and 
grape extract. The vitamin supplementation resulted in the highest 
level of cholesterol in feces samples, and the consumption of grape 
extract alone also favored presence of higher levels of cholesterol 
in feces in comparison with control animals (Table 1), suggesting 
that these treatments might have been effective in exerting 
hipocholesterolemic effect through fecal excretion mechanism. 
The treatments did not influence the serum and liver 
triacylglycerol levels. However, grape extract intake led to a 
significant increase in total triacylglycerol fecal excretion compared 
with control (Table 1).
TABLE 1 - Apo E-/- mice experimental groups’ serum, 
liver and fecal total cholesterol and triacylglycerol levels. 
Data are given as means ±SEM * p<0.05 compared with control group. 
†p<0.05 compared with grape group. ‡p<0.05 compared with tocopherol 
goup (ANOVA analysis of variance).
Serum and liver vitamin E levels and soluble polyphenol
The use of antioxidants as part of the diet tended to enhance 
vitamin E serum levels around 2.2, 2.8 and 3.7 times respectively in 
animals receiving tocopherol, grape extract and tocopherol + grape 
compared to control group, although no statistical significance was 
found. While groups receiving grape extract, either isolated or in 
association with -tocopherol, presented higher vitamin E serum 
levels, their hepatic content of this vitamin was smaller in relation 
to control group (Table 2).
The grape extract treatment did not alter the serum and 
liver levels of polyphenols; however, the groups receiving grape 
extract presented fecal content of polyphenols smaller than control 
and tocopherol group (Table 2). 
TABLE 2 - Apo E-/- mice experimental groups’ serum, 
liver and fecal vitamin E and soluble polyphenol levels. 
Data are given as means ±SEM. * p<0.05 compared with control group. 
†p< 0.05 compared with grape group. ‡p<0.05 compared with tocopherol 
goup (ANOVA analysis of variance).
Malondialdehyde and lipid hydroperoxide
The treatments did not influence the liver levels of MDA 
and the lipid hydroperoxide levels. However, these levels tended to 
reduce with consumption of both antioxidants (Data not shown).
Liver and fecal fatty acid profile
Interventions with antioxidants had different impact on the 
fatty acid profile of the liver: supplementation with α-tocopherol 
preserved oleic fatty acid (C18:1) as compared with grape extract 
consumption, while the group fed grape extract presented a higher 
DHA (C22:6) fatty acid percentage (Table 3). 
Lipid Control Tocopherol Grape Grape andTocopherol
Total Cholesterol n= 12 n= 9 n= 12 n= 12
Serum(mg/dL) 1024.71 ± 83,21 657.36 ± 69.65* 863.74 ± 132.47* 578.56 ± 196.27*†
Liver (mg/g) 25.78 ± 2.61 13.20 ± 3.13* 14.23 ± 3.32* 8.39 ± 2.01*†
Fecal(mg/g)* 14.77 ± 2.52 24.97 ± 0.54*† 22.21 ± 3.63*‡ 18.27 ± 1.91*†‡
Triacilglycerol n= 6 n= 6 n= 6 n= 6
Serum(mg/dL) 204.07 ± 90.00 132.21 ± 30.01 146.07 ± 62.77 127.43 ± 45.17
Liver (mg/g) 85.78 ± 24.58 87.41 ± 12.94 63.34 ± 14.67 83.68 ± 24.12
Fecal(mg/g) 2.04 ± 1.07 - 17.21 ± 3.54* 17.91 ± 1.20*
Parametrer Control Tocopherol Grape Grape andTocopherol
Vitamin E n= 6 n= 5 n= 5 N= 7
Serum (mg/dL)
Stample pool 2.24 4.95 6.45 8.25
Liver (µg/g) 16.23 ± 1.96 19.79 ± 6.89 6.93 ± 1.70* 8.90 ± 2.27*‡
Soluble polyphenal n= 10 n= 9 n= 10 n= 10
Serum(mg/dL) 4.33 ± 0.81 4.81 ± 0.27 4.15 ± 0.60 4.28 ± 1.47
Liver (mg/g) 6.82 ± 2.66 7.44 ± 3.44 4.29 ± 2.01 4.69 ± 1.84
Fecal(mg/g) 1.68 ± 0.27 1.94 ± 0.07 0.58 ± 0.13*‡ 0.70 ± 0.17*‡
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TABLE 3 - Apo E-/- mice experimental groups’ liver fatty 
acid profile. 
Data are given as means ±SEM. * p<0.05 compared with control group. 
†p<0.05 compared with grape group. ‡p<0.05 compared with tocopherol 
goup (ANOVA analysis of variance). ND= undetermined value.
Fecal fatty acid profile was reduced in DHA when the 
animals were fed α-tocopherol, suggesting that this vitamin may 
contribute to DHA absorption. The antioxidant treatments provided 
a slight increase in the fecal excretion of saturated fatty acids and 
smaller excretion of mono and polyunsaturated fatty acids (Table 4). 
TABLE 4 - Apo E-/- mice experimental groups’ fecal fatty 
acid profile.
Data are given as means ±SEM. * p<0.05 compared with control group. 
†p<0.05 compared with grape group. ‡p<0.05 compared with tocopherol 
goup (ANOVA analysis of variance).
 Morphological analysis of aorta
In the morphological analysis of the sections, no difference 
was observed in relation to size of the atherosclerotic lesion area, 
but about the degree of atherosclerotic lesion development. The 
group receiving the grape extract combined with α-tocopherol 
didn’t present any lesion at advanced stage. Animals receiving just 
α-tocopherol supplementation showed a better profile of lesion 
classification in comparison to control and grape extract group 
(Table 5).
TABLE 5 - Morphological classification of specific 
histopathological characteristics of six different degrees of 
atherosclerotic lesion.
*According to classification proposed by Stary et al.17 †p<0.05 compared 
with control group according to chi-square test.
Discussion
Evidences of polyphenols benefits are usually derived 
from in vitro or animals experiments which usually applies higher 
doses than those usually consumed by humans18. Our treated mice 
consumed a dose of approximately 1600mg of polyphenols/kg of 
body weight and 1200 mg of anthocyanins/kg of body weight, a 
very high quantity if we consider men’s average intake of flavonoids 
assessed by Hertog et al.19 around 25mg/day, which would represents 
an average dose of 0.33 mg/kg body weight for an average man of 
75 kg. At this relative low level of intake, they found that flavonoid 
intake was significantly inversely associated with mortality from 
coronary heart disease in humans. 
Administration of grape extract and α-tocopherol reduced 
serum and hepatic cholesterol levels, although this effect has been 
potentiated when these antioxidants were given together. This 
hypocholesterolemic effect of the polyphenols was also observed by 
Yang and Koo20. In their study they used polyphenols from green tea 
and observed a reduction in the levels of serum and liver cholesterol 
in hypercholesterolemic mice. The same effect was not observed 












Saturated 39.06 ± 21.15 32.62 ± 6.19 24.10 ± 18.72 27.77 ± 17.96
C16:0 36.19 ± 7.72 29.50 ± 5.69 31.87 ± 9.08 31.98 ± 11.09
C18.0 4.94 ± 2.30 4.37 ± 1.63 6.98 ± 3.62 7.45 ± 4.72
Monounsaturated 48.06 ± 5.03 49.13 ± 13.08 36.39 ± 13.66 39.75 ± 9.54
C16:1 48.06 ± 5.03 2.93 ± 1.08 2.46 ± 1.63 2.44 ± 0.99
C18:1 2.51 ± 0.83 47.50 ± 14.13† 32.57 ± 14.30‡ 36.97 ± 8.25
Polyunsaturated 43.58 ± 7.77 24.53 ± 11.91 34.35 ± 14.64 31.08 ± 8.51
C18:2 ω6 26.49 ± 7.02 20.02 ± 10.06 12.53 ± 2.12 13.19 ± 2.36
C18:3 ω3 14.57 ± 2.72 ND 0.84 ± 0.37 ND
C20:4 ω6 1.35 ± 0.08 5.78 ± 1.38 11.88 ± 6.16 10.04 ± 4.38












Saturaded 24.61 ± 18.41 74.41 ± 6.35 37.23 ± 18.53 41.03 ± 37.59
C16:0 17.63 ± 11.13 22.92 ± 1.88 24.89 ± 0.87 22.48 ± 3.43
C18:0 22.03 ± 0.17 46.48 ± 5.06* 37.13 ± 1.95* 30.27 ± 2.08
Monounsaturated 32.00 ± 31.64 20.36 ± 4.70 22.36 ± 24.36 20.43 ± 17.70
C18:1 23.30 ± 19.68 17.84 ± 19.68 15.53 ± 5.84 21.91 ± 7.17
Polyunsaturated 29.47 ± 14.42 23.23 ± 32.18 19.80 ± 2.27 14.37 ± 5.06
C18:2 ω6 8.04 ± 2.51 4.08 ± 0.71 5.22 ± 1.64 5.22 ± 2.92
C22:6 ω3 19.71 ± 4.69 3.71 ± 3.80* 14.58 ± 3.89 9.75 ± 6.48
Group
Proportion of lesion classified at
each stage* development
Initial Intermediate Advanced
Control (n=12) 0% 50% 50%
Tocopherol (n=8) 37,5% 50% 12,5%
Grape extrac (n=15) 13,3% 53,3% 33,4%
Grape extract and 
tocopherol (n=15) † 30% 70% 0%
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Cyrus et al.22 and Koga et al.23. These authors did not observed any 
reduction in the levels of cholesterol in Apo E-/- rats, LDL -/- rats 
and rabbits, respectively, treated with different doses of vitamin E.
The hypocholesterolemic effect of these antioxidants 
may be attributed to the action of these substances on cellular 
metabolism. Polyphenols found in non-alcoholic wine decrease Apo 
B lipoprotein synthesis by liver cells, thus decreasing the production 
of lipid-transporting lipoproteins in the plasma. Both, polyphenols24 
and vitamin E25 seem to increase the expression of LDL receptors 
in the cells, increasing cholesterol uptake by the liver cells and 
reducing the cholesterol plasma levels.
The serum and liver levels of the triacylglycerols, on the 
other hand, were not influenced by the treatments, a result similar 
to those found by Yang and Koo20, in hypercholesterolemic rats fed 
green tea polyphenols. In the present study, a significant increase was 
observed in the fecal excretion of triacylglycerol and cholesterol. 
This effect could have been attributed to the interaction between 
polyphenols and the digestive proteins, altering lipid metabolism 
and reducing the bioavailability of these substances26. Polyphenolic 
substances can have an anti nutritional action compromising 
intestinal permeability and, consequently, animal nutrition27, as well 
as their interaction with the pancreatic lipases, decreasing the action 
of the enzyme and compromising the bioavailability of the lipids28.
Antioxidant capacity would be related to the modulation 
of oxidative stress. The progression of the atherosclerotic lesion 
involves an inflammatory process, where chemokines controls 
the recruitment of leukocytes within the vascular wall and these 
activated cells contribute to oxidative stress29. Increased serum 
levels of vitamin E of the groups treated reflects the enhancement of 
antioxidant capacity. The groups fed grape polyphenols were found 
to obtain a similar result regarding vitamin E serum levels to that 
obtained with α-tocopherol supplementation or even superior when 
the two antioxidants were administered. Such result may have been 
due to the action of α-tocopherol recovery by the polyphenols30. 
However, the results found regarding vitamin E levels in the liver 
suggest that the presence of polyphenols in the diet could mobilize 
liver vitamin reserves. 
Polyphenols bioavailability determines their effects. 
Indirect evidence of their absorption through the gut barrier is the 
increase in the antioxidant capacity of the plasma with polyphenol-
rich foods18. Bub et al.31 administered fruit juices providing 
polyphenolic compounds to men during 2 weeks. Twelve hours after 
the last ingestion of juices no polyphenols or polyphenol metabolites 
from either juices were detected in plasma or urine samples, but 
positive results were found in the group supplemented.  In our 
study, although no difference in plasma and liver polyphenol levels 
were found between the groups, animals receiving grape extract 
presented fecal content of polyphenols smaller than control and 
tocopherol group. This could indicate that supplemented animals 
absorbed polyphenol from the juice or may have been due to the 
interaction of the polyphenols with the enteric enzymes. The plasma 
levels tend to be constant, even during supplementation, when the 
polyphenol urinary excretion levels seem to increase proportionally 
to intake increase20.  
Although not presenting any statistical difference, the 
indicators of peroxidation in the present study tended to reduce 
these indices in the treatment using both antioxidants. These results 
were similar to those found by Stoker and O’Halloran32, where no 
differences were observed in lipid peroxidation of ApoE-/-mice 
treated for 24 weeks with non-alcoholic red wine. Slight increase was 
observed in the formation of hydrogen peroxides, as in the present 
study, but with no statistical significance. Kaplan et al.33 observed a 
reduction of 8% in lipid peroxidation in the plasma of Apo E-/- mice 
fed pomegranate juice, rich in polyphenols. Blackhurst and Marais34 
in a study with eutrophic humans did not observe any alteration 
in lipid peroxidation after red wine intake, although there was a 
significant increase in the polyphenol plasma levels. Zhao et al.35 
observed a reduction in lipid peroxidation in Apo E-/- mice fed diet 
supplemented with vitamin E
Fatty acid change can alter the properties of the cellular 
membranes and, consequently, their participation in the lipid 
metabolism36. The liver fatty acid profiles were not influenced by the 
treatments; however, despite non-significant, a greater preservation 
of the polyunsaturated fatty acids was observed in the polyphenol-
fed groups (greater preservation of oleic acid in groups treated in 
comparison to control group). Such result may be an expression of 
solubility of the antioxidants studied. Hydrophilic phenolic extracts, 
sequesters of free radicals such as polyphenols, would be more 
effective antioxidants than the hydrophobic ones, such as vitamin 
E, in systems where there is an oil-water interface, such as the one 
found in the liver tissue37. 
Treatment using antioxidants was not capable of altering 
lesion size; however, there was a change in the degree of evolution 
of the atherosclerotic lesion, a result similar to that found by Nakata 
and Maeda38, where researchers studied food supplementation with 
vitamin C in Apo E-/ mice. In the same animal model, Peluzio et 
al.21 observed a significant reduction in the size of the lesions and 
smaller development degree, after vitamin E supplementation of 400 
UI/Kg of diet. Zhao et al.35 observed a reduction in atherosclerosis 
progression following food supplementation of vitamin E, with 
2000UI/Kg of diet. 
The polyphenol study reveals a reduction in the progression 
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of the atherosclerotic plaques. Fuhman et al.39 observed a reduction 
in the degree of development of the atherosclerotic lesion after 
consumption of ginger polyphenols without pre induction of 
atheromatous plaque. Aviran et al.40 and Kaplan et al.41observed 
reduction in the size of atherosclerotic lesion after pomegranate 
juice intake. Oral supplementation with non-alcoholic wine 32 and 
caffeic acid 41 were also capable of reducing the development of the 
atherosclerotic lesion. 
Conclusions
1.  Intake of antioxidants, such as the polyphenols found 
in grape, and α-tocopherol had a beneficial effect on atherosclerosis, 
contributing to reduce the degree of evolution of the atherosclerotic 
lesion, reduction of serum and liver cholesterol levels, increase of 
cholesterol and triacylglycerol fecal excretion.
2. A synergistic effect between the polyphenols and 
α-tocopherol was observed, resulting in a greater beneficial effect 
on atherosclerosis than the isolated consumption of antioxidants.
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